Clinical Trial Update: Long COVID-19 Cutaneous Signatures: An ARPA Funded Research Project

View source ↗

Summary

ARPA-funded clinical trial update investigating cutaneous signatures associated with long COVID and acute COVID-19; current status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy
• Post-acute Sequelae of Sars-cov-2 Infection
• Postural Orthostatic Tachycardia Syndrome

Snippet

Sponsor: CND Life Sciences | Conditions: Long COVID-19, Acute COVID-19 | Status: ACTIVE_NOT_RECRUITING